- Home
- PMVP vs IHD Comparison
PMVP vs IHD Comparison
Compare PMVP & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMVP | IHD |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 126.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | IHD |
|---|---|---|
| Price | $1.58 | $6.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 812.0K | 150.2K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $4.54 |
| 52 Week High | $1.88 | $7.28 |
Technical Indicators
Market Signals| Indicator | PMVP | IHD |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 32.11 |
| Support Level | $1.32 | $6.12 |
| Resistance Level | $1.86 | $7.19 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 63.95 | 6.35 |
Price Performance
Historical ComparisonAbout PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.